Getinge Enters New Agreement with HealthTrust to Provide Hospitals and Healthcare Systems Access to Portfolio of Infection Control Solutions

Leading group purchasing organization (GPO) with over 1,600 hospital partners will now have access to Getinge sterilizers and washers

Getinge announced that it has been awarded an infection control contract from HealthTrust, a national group purchasing organization (GPO) and performance improvement authority for healthcare.

This contract will bring Getinge’s innovative infection control product portfolio to HealthTrust members for the first time in over a decade.

“We are proud that HealthTrust has awarded their respected infection control contract to Getinge,” said Patricia Fitch, President of Getinge North America. “This will give HealthTrust members easier access to our full breadth of infection control solutions that can help to improve the safety and efficiency of sterile processing departments.”

This contract will give HealthTrust members access to Getinge’s family of infection control products at a contract rate. These products and solutions include sterilizers like the GSS67N that are designed to optimize the sterile processing department with faster throughput and help maximize uptime through Getinge Online. The contract also includes a variety of washers including the Getinge S-8668TGetinge 9100E, and ultrasonic systems. These washers come equipped with features designed to help improve the speed, efficiency, and reliability of the sterile processing department.

“This contract highlights Getinge’s commitment to designing innovative solutions that meet the needs of our customers,” said John Pietrantoni, Vice President Corporate Accounts. “We have invested heavily in research and development to bring unique solutions to the marketplace that help maximize space at hospitals and ambulatory surgery centers (ASC), optimize automation and support sustainability goals.”

Getinge will offer individual consulting services to hospitals and healthcare systems that are looking to personalize their space and get the most out of their infection control solutions. Getinge’s products are designed to accommodate the department’s individualized needs such as space constraints, throughput, automation, and connectivity.

The company’s newest washers and sterilizers have been designed with the latest technology to monitor, record, and optimize water, energy, and consumables, like detergent consumption, visible through detailed process reports. This is designed to minimize environmental impact, and promote sustainability throughout all sterile processing processes.

“This contract is a reflection of our commitment to delivering sustainable products and solutions to hospital systems to improve workflows and aid in the safety of patients and healthcare workers,” said Ms. Fitch. “We are excited for the thousands of HealthTrust members who now have special access to our infection control product portfolio.”

SourceGetinge

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version